Back This Medical AI Tech
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Financials
| Curr Year EPS Estimate | -4.16 |
| Next Quarter EPS Estimate | -0.82 |
| Profit Margin | -115.60% |
| Operating Margin | -120.52 |
| Return on Assets | -0.28 |
| Return on Equity | -0.52 |
| Revenue | 219.7M |
| Earnings Per Share | -3.41 |
| Revenue Per Share | 2.95 |
| Gross Profit | 204,795,008 |
| Quarterly Revenue Growth | 1.34 |
General
| Name | SpringWorks Therapeutics Inc |
| Ticker | SWTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 368 |
About SpringWorks Therapeutics Inc
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. It offers OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor for the treatment of desmoid tumors; and GOMEKLI (mirdametinib), an oral small molecule inhibitor of MEK1 and MEK2 for the treatment of adult and pediatric patients two years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). The company also develops Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer; and mirdametinib for the treatment of solid tumors harboring other MAPK aberrations, including for the treatment of pediatric and young adult patients with low-grade gliomas that is in Phase 1/2 clinical trial. In addition, its products under development include Brimarafenib (BGB-3245), an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations. The company has license agreements with Pfizer Inc. for nirogacestat and mirdametinib; and Katholieke Universiteit Leuven and the Flanders Institute for Biotechnology for a portfolio of novel small molecule inhibitors of the TEA Domain. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut.
Earnings
Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not
WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.
Cathie Wood's Alpha Surge: $250 Million Circle Windfall, Big AMD Buys
Cathie Wood, founder and CEO of ARK Invest, has recently been on a hot streak of successful and high-profile trades through her flagship ARK ETFs.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.
This Stock Just Popped 30% In 5 Days — Now Expert Says It 'Looks Potentially Explosive'
Experts have been betting on the growth prospects of Oscar Health, as it surged by 16.51% on Wednesday and 32.56% in the last five days.
Iran’s president orders country to suspend cooperation with UN nuclear watchdog IAEA
DUBAI, United Arab Emirates (AP) — Iran’s president on Wednesday ordered the country to suspend its cooperation with after American and Israeli airstrikes hit its most-important nuclear facilities, likely further limiting inspectors' ability to track Tehran's program that had been enriching uranium to near weapons-grade levels.
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
Mexican banks face cascading consequences following US sanctions
Mexico City (AP) — Three Mexican financial institutions sanctioned by the Trump administration last week have felt a cascade of economic consequences following the allegations that they helped launder millions of dollars for drug cartels.
Greenland has a message for the rest of the world: Come visit
NUUK, Greenland (AP) — has a message for the rest of the world: We’re waiting for you.
The Missing Ingredient for Big Tech's $3T Recipe? - Ad
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
Trump's Tariffs, Boeing's Blowout, Tesla's Robotaxi, BYD's European Triumph And GM's Massive Recall: This Week In Mobility
This week's business and finance highlights include Japan's rejection of Trump's auto tariffs, Boeing's scrutiny over a mid-air incident, Tesla's Robotaxi launch, BYD's dominance in Europe, and GM's massive vehicle recall.
Trump vents online about service provider after conference call marred by glitch
WASHINGTON (AP) — On Monday afternoon, the president of the United States was just another person complaining online about his service provider.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
BigBear.ai (BBAI) Stock Soars 21%: What's Going On?
Shares of BigBear.ai are trading sharply higher Tuesday afternoon. The rally comes without any new company-specific announcements.
What's in the latest version of Trump's big bill moving through the Senate
WASHINGTON (AP) — Republicans are inching closer to getting their tax and spending cut bill through Congress with a final Senate vote likely late Monday or early Tuesday.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Shooting Stars: Rocket Lab Breaks Records (And Stock Up 640% In Past Year), AST SpaceMobile Impresses Defense, Kuiper Grows
Here's a look at recent highlights, news catalysts and upcoming events in the space stock sector.
Trump's Approval Ratings, Tariff Deadlines, Schumer's Criticism, And Defense Budget Shifts: This Week In Politics
Trump's approval ratings drop after Iran attack, hints at tariff deadline flexibility. SC limits judges' power, Schumer criticizes GOP budget, defense budget shifts to missiles and drones.
Our No.1 AI Stock Has Nothing to Do With Tech - Ad
Nvidia CEO Jensen Huang recently said AI requires "100 times more" power. We believe that means the best way to invest in AI right now has nothing to do with technology ... And everything to do with energy. One stock appears to be perfectly positioned...
Trump's Crypto Ventures, Draper And Cathie Wood's Bitcoin Predictions, MSTR Estimates, And More: This Week In Crypto
The past week in the world of cryptocurrency was nothing short of eventful. From legislative moves aimed at curbing alleged corruption in cryptocurrency ventures to bold predictions about Bitcoin’s dominance, the week was filled with intriguing developments. Here’s a quick recap of the top stories that made headlines.
A hard-right lawmaker is sworn in as Greece's migration minister
ATHENS, Greece (AP) — A hard-right lawmaker was sworn in Monday as Greece’s migration minister, replacing a fellow right-wing political heavyweight who resigned following
The Unlikely Duo Rethinking Wearable Technology - Ad
Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.
Inside The Trump Family's $620 Million Crypto Empire
Since retaking the White House, Donald Trump's reported net worth has remained broadly stable, around $6.5 billion on Election Day to roughly $6.4 billion today.
What's in the latest version of Trump's big bill that passed the Senate
WASHINGTON (AP) — Republicans are getting closer to the finish line in getting their tax and spending cut bill through Congress with a final House vote possible on Wednesday.
You Voted for Trump. You Didn't Vote for This... - Ad
Markets in chaos-stocks wiped out, tariffs from the 1930s, agencies collapsing. But it's not random: Trump's "GREAT RESET" is a four-year plan to reset markets, risking $10T in value. Discover if your retirement is in danger and learn the one trade that could turn $1,000 into $29,000 by the end of 2026.
How a GOP rift over tech regulation doomed a ban on state AI laws in Trump's tax bill
NEW YORK (AP) — A controversial bid to deter states from regulating artificial intelligence for a decade seemed on its way to passing as the championed by worked its way through the U.S. Senate.
CoreWeave Stock Rallied On Thursday: What Happened?
Shares of CoreWeave Inc. (NASDAQ: CRWV) traded higher on Thursday with gains accelerating into the close. The company announced it became the first AI cloud provider to deploy NVIDIA Corp's (NASDAQ:NVDA) new GB300 NVL72 platform.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Denmark tests unmanned robotic sailboat fleet with tensions high in the region
KOGE MARINA, Denmark (AP) — From a distance they look almost like ordinary sailboats, their sails emblazoned with the red-and-white flag .
Elon Musk renews his criticism of Trump's big bill as it faces a key Senate vote
WASHINGTON (AP) — on Saturday doubled down on his distaste for President sprawling tax and spending cuts bill, arguing the that Republican senators are scrambling to pass would kill jobs and bog down burgeoning industries.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Spanish court rejects Airbnb appeal and keeps order to block nearly 66,000 listings
MADRID (AP) — A Spanish court on Thursday rejected an appeal by Airbnb and left in place an order to block almost 66,000 rental listings that the government said violated local rules.
Michael Novogratz's Galaxy And Invesco File To Launch Solana ETF: What You Should Know About QSOL
Asset management giant Invesco filed for a cryptocurrency exchange-traded fund focused on Solana (CRYPTO: SOL) on Wednesday, expanding its offerings beyond Bitcoin (CRYPTO: BTC).
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.
Air India faces turbulence as plane crash prompts deeper checks and disruptions
NEW DELHI (AP) — Air India is facing fresh turbulence following last week’s fatal crash as additional safety inspections on its Dreamliner fleet have led to flight delays, cancellations and growing passenger anxiety.
US job openings in May hit 7.8 million in a continuing display of labor market resilience
WASHINGTON (AP) — U.S. job openings rose unexpectedly in May, a sign that the American labor market t in the face of high borrowing costs and uncertainty over U.S. economic policy.
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
Scott Bessent On Replacing Powell As Fed Chair: 'I Will Do What The President Wants' — Plays Down Shadow Chair Speculations
U.S. Treasury Secretary Scott Bessent declined to rule out the possibility of replacing Jerome Powell as Federal Reserve Chair and has instead deferred to President Donald Trump's decision on the matter.
Dave Ramsey Suggests Pausing Retirement Savings To Speed Up Home Down Payment, Warns 'Don't Borrow From or Cash Out Your Retirement Accounts To Speed Up Your Down Payment Savings'
Dave Ramsey has suggested a unique strategy for Americans grappling with the challenge of saving for a home down payment amidst escalating inflation and living costs.
The Missing Ingredient for Big Tech's $3T Recipe? - Ad
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
US brings charges in North Korean remote worker scheme that officials say funds weapons program
WASHINGTON (AP) — The Justice Department announced criminal charges Monday in connection with a scheme by North Korea to fund its weapons program through the salaries of remote information technology workers employed unwittingly by U.S. companies.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.